Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00852163 · ClinicalTrials.gov registry record · Phase 2
Study of Stem Cell Transplant for Leukemia and Myelodysplastic Syndromes Using Clofarabine and Busulfan Regimen
A Phase 2 study, sponsored by Baylor Research Institute.
- Completed
- Registry status
- Phase 2
- Development phase
- 20
- Enrollment target
NCT00852163 is a Phase 2 study that has completed, run by Baylor Research Institute. The registered enrollment target is 20 participants.
The verdict
NCT00852163, a Phase 2 study, has completed, sponsored by Baylor Research Institute.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether Clofarabine in combination with Busulfan is effective as a preparative transplant regimen for the treatment of leukemia and myelodysplastic syndromes
Interventions
- DRUG Clofarabine with Busulfan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2007-03 |
| Est. Completion | 2011-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00852163
The ClinicalTrials.gov registry entry for NCT00852163 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor Research Institute, which has 180 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Clofarabine with Busulfan is the first listed.
NCT00852163 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00852163 about?
NCT00852163 is a clinical study titled "Study of Stem Cell Transplant for Leukemia and Myelodysplastic Syndromes Using Clofarabine and Busulfan Regimen". The purpose of this study is to determine whether Clofarabine in combination with Busulfan is effective as a preparative transplant regimen for the treatment of leukemia and myelodysplastic syndromes
What is the current status of trial NCT00852163?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2007-03. Estimated completion is 2011-12.
What interventions are being tested in trial NCT00852163?
The interventions under investigation include: Clofarabine with Busulfan (DRUG).
Who is sponsoring clinical trial NCT00852163?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.